Tweet
Several ideas :
1. BDSI is interesting : READ This from a previous post
Found this nice BDSI summation done by a Motley Fool writer.
BioDelivery Sciences awaits word on its opioid dependence drug
Small-cap biotech BioDelivery Sciences is hoping to have the U.S. Food and Drug Administration approve its New Drug Application, or NDA, for Bunavail by June 7 as a treatment for opioid abuse. The company believes Bunavail could see peak sales of up to $250 million a year as an alternative to Suboxone, a sublingual film consisting of ingredients similar to Bunavil. According to BioDelivery, Suboxone generated over $1 billion in sales in the past year as a treatment for opioid dependence.
What's key to understand is that Bunavil's primary difference is that it's placed inside the cheek instead of under the tongue like Suboxone. And given that Bunavil appears to be a bioequivalent of Suboxone per the clinical data, I don't see this regulatory review as a major hurdle to approval. In light of BioDelivery's tiny market cap of $355 million compared with Bunavil's commercial potential, you may want to get this stock on your watch list.
Sentiment: Strong Buy
FOLKS "NOTE" The "STRONG BUY Recommendation for BDSI
Folks BDSI is going for approval of their drug BUNAVAIL on June 7, 2014 It should begin a slow rise until that date , and then RISE or FALL sharply based on the FDA decision. IMHO money can be made by holding till almost June 7th , and then selling before the decision. http://finviz.com/quote.ashx?t=bdsi&ty=c&ta=1&p=d
2. GTAT my 2nd pick for my own Low Priced Money Bonanza appears to be coming alive! http://finviz.com/quote.ashx?t=gtat&ty=c&ta=1&p=d
3. DRTX Also has a drug up for an FDA decision , but that will occur on May 26, 2014 . You may wish to follow the same plan as above! http://finviz.com/quote.ashx?t=drtx&ty=c&ta=1&p=d Another DRTX Chart: http://scharts.co/1iDTM4d
***** BONUS DARK HORSE EXEL Earnings come out today , after the market close , and buying before that time could be precarious, but let us see what happens with EXEL! Folks EXEL has already taken a good beat down , so a good earnings report will cause EXEL to ROCKET UP! http://finviz.com/quote.ashx?t=exel&ty=c&ta=1&p=d
Folks as always none of these stocks is guaranteed to rise , and please remember you can lose money in any or all of them!
RAD Most of us had been in a Rite Aid Drug store , and my MTS computer program scores RAD a huge 98 out of 100. Going back to 6/25/12 had you placed 10K into RAD and followed the MTS signals to buy and sell you would have $39,167 , and the program can pick stocks with a 90% accuracy!
Would ys just look at this sweet chart http://finviz.com/quote.ashx?t=rad&ty=c&ta=1&p=d
Previous pick XXII took a huge beating , but as all good fighters..... is up off the canvas and looks ready to go! I will wait to a GREEN BUY signal appears on my MTS computer program , and then I may buy in once again. http://scharts.co/1iDUdvr
1. BDSI is interesting : READ This from a previous post
Found this nice BDSI summation done by a Motley Fool writer.
BioDelivery Sciences awaits word on its opioid dependence drug
Small-cap biotech BioDelivery Sciences is hoping to have the U.S. Food and Drug Administration approve its New Drug Application, or NDA, for Bunavail by June 7 as a treatment for opioid abuse. The company believes Bunavail could see peak sales of up to $250 million a year as an alternative to Suboxone, a sublingual film consisting of ingredients similar to Bunavil. According to BioDelivery, Suboxone generated over $1 billion in sales in the past year as a treatment for opioid dependence.
What's key to understand is that Bunavil's primary difference is that it's placed inside the cheek instead of under the tongue like Suboxone. And given that Bunavil appears to be a bioequivalent of Suboxone per the clinical data, I don't see this regulatory review as a major hurdle to approval. In light of BioDelivery's tiny market cap of $355 million compared with Bunavil's commercial potential, you may want to get this stock on your watch list.
Sentiment: Strong Buy
FOLKS "NOTE" The "STRONG BUY Recommendation for BDSI
Folks BDSI is going for approval of their drug BUNAVAIL on June 7, 2014 It should begin a slow rise until that date , and then RISE or FALL sharply based on the FDA decision. IMHO money can be made by holding till almost June 7th , and then selling before the decision. http://finviz.com/quote.ashx?t=bdsi&ty=c&ta=1&p=d
2. GTAT my 2nd pick for my own Low Priced Money Bonanza appears to be coming alive! http://finviz.com/quote.ashx?t=gtat&ty=c&ta=1&p=d
3. DRTX Also has a drug up for an FDA decision , but that will occur on May 26, 2014 . You may wish to follow the same plan as above! http://finviz.com/quote.ashx?t=drtx&ty=c&ta=1&p=d Another DRTX Chart: http://scharts.co/1iDTM4d
***** BONUS DARK HORSE EXEL Earnings come out today , after the market close , and buying before that time could be precarious, but let us see what happens with EXEL! Folks EXEL has already taken a good beat down , so a good earnings report will cause EXEL to ROCKET UP! http://finviz.com/quote.ashx?t=exel&ty=c&ta=1&p=d
Folks as always none of these stocks is guaranteed to rise , and please remember you can lose money in any or all of them!
RAD Most of us had been in a Rite Aid Drug store , and my MTS computer program scores RAD a huge 98 out of 100. Going back to 6/25/12 had you placed 10K into RAD and followed the MTS signals to buy and sell you would have $39,167 , and the program can pick stocks with a 90% accuracy!
Would ys just look at this sweet chart http://finviz.com/quote.ashx?t=rad&ty=c&ta=1&p=d
Previous pick XXII took a huge beating , but as all good fighters..... is up off the canvas and looks ready to go! I will wait to a GREEN BUY signal appears on my MTS computer program , and then I may buy in once again. http://scharts.co/1iDUdvr
Comment